SynthesisDrug design, development and therapy2015

Incidence and risk of hypertension with bevacizumab in non-small-cell lung cancer patients: a meta-analysis of randomized controlled trials.

Jian Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.